InvestorsHub Logo

KnowNothingJonSnow

01/12/24 1:34 PM

#420303 RE: JRoon71 #420302

What is the only one in the planet who cares about Mitigate. It was a f’in COVID study. JFC.

Whalatane

01/12/24 1:49 PM

#420306 RE: JRoon71 #420302

JR / Zip From memory, data is released if the trial was stopped for futility or because of serious adverse events . We don't know why MITIGATE was terminated do we ? Kaiser was very proactive in getting everyone with the MITIGATE profile Covid vaccinated so this baseline ( number vaccinated ) would have changed drastically throughout the trial confounding the results ???
I thought the following was important from the CC

As examples, in Spain we launched in September. You may recall I shared in Q3 that we had about 500 patients on therapy in Spain at the end of Q3. We now estimate we have more than 1,700 patients in Spain, which demonstrates a really strong uptake and we're pleased with that and we're really only at the early stages.


They now have more on Vazkepa in Spain vs the UK .
If they can do the same in Italy ...and keep the script numbers accelerating in both while controlling costs etc ...PPS should trend higher
JMO
Kiwi